ВСЯ ПРАВДА О ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ

Abstract

The management of the patients with atrial fibrillation is the global problem of the modern cardiology and internal medicine because of the associated high mortality risk and severe complications. Drug therapy, especially antithrombotic, becomes a difficult question in case of patient with comorbidity conditions. Though there are some new more effective and safe drugs that becomes more popular and convenient for patients. To reduce the amount of thrombotic complications is the main aspect. And only the outpatient departments can provide patients with atrial fibrillation with the adequate antithrombotic prevention. But nowadays this field doesn’t work as it should according to the European and National Guidelines. So this article speaks about alive and dead patients with atrial fibrillation, about their management in out-patient and in-patient department and about the way they should be treated according to Guidelines.

Keywords

• atrial fibrillation
• thrombotic complications
• ischemic stroke
• myocardial infarction
• pulmonary embolism
• comorbidity
• out-patient care
• rivaroxaban
• warfarin
• dabigatran etexilate
• antithrombotic therapy